Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-05

FDA Approved: LORATADINE — Supplemental Application (Wal-Mart Stores, Inc)

View source ↗

Summary

FDA approved a supplemental application for loratadine submitted by Wal-Mart Stores, Inc., updating an already approved product under ANDA210088.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)

Snippet

SUPPL AP for LORATADINE (LORATADINE)